Literature DB >> 26488027

Acute hepatitis after amiodarone infusion.

Paulo Fonseca1, Adelaide Dias1, Helena Gonçalves1, Aníbal Albuquerque1, Vasco Gama1.   

Abstract

Acute hepatitis is a very rare, but potentially fatal, adverse effect of intravenous amiodarone. We present a case of an 88-year-old man with history of ischemic dilated cardiomyopathy and severely depressed left ventricular function that was admitted to our coronary care unit with diagnosis of decompensated heart failure and non-sustained ventricular tachycardia. A few hours after the beginning of intravenous amiodarone he developed an acute hepatitis. There was a completely recovery within the next days after amiodarone withdrawn and other causes of acute hepatitis have been ruled out. This case highlights the need for close monitoring of hepatic function during amiodarone infusion in order to identify any potential hepatotoxicity and prevent a fatal outcome. Oral amiodarone is, apparently, a safe option in these patients.

Entities:  

Keywords:  Amiodarone; Hepatitis; Hepatotoxicity; Idiosyncratic reactions; Polysorbate 80

Year:  2015        PMID: 26488027      PMCID: PMC4607809          DOI: 10.12998/wjcc.v3.i10.900

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  15 in total

1.  Acute toxic hepatitis after amiodarone intravenous loading.

Authors:  Emanuela Rizzioli; Elena Incasa; Susanna Gamberini; Sandra Savelli; Arnaldo Zangirolami; Marilena Tampieri; Roberto Manfredini
Journal:  Am J Emerg Med       Date:  2007-11       Impact factor: 2.469

2.  Role of Oxidative Stress in Amiodarone-induced Toxicity.

Authors: 
Journal:  J Cardiovasc Pharmacol Ther       Date:  1997-01       Impact factor: 2.457

3.  Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients.

Authors:  J H Lewis; R C Ranard; A Caruso; L K Jackson; F Mullick; K G Ishak; L B Seeff; H J Zimmerman
Journal:  Hepatology       Date:  1989-05       Impact factor: 17.425

4.  Lessons from the E-Ferol tragedy.

Authors:  W F Balistreri; M K Farrell; K E Bove
Journal:  Pediatrics       Date:  1986-09       Impact factor: 7.124

5.  Mechanisms of benzarone and benzbromarone-induced hepatic toxicity.

Authors:  Priska Kaufmann; Michael Török; Anya Hänni; Paul Roberts; Rodolfo Gasser; Stephan Krähenbühl
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

6.  Acute amiodarone-induced hepatitis.

Authors:  N Kalantzis; P Gabriel; J Mouzas; D Tiniakos; D Tsigas; G Tiniakos
Journal:  Hepatogastroenterology       Date:  1991-02

7.  Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle?

Authors:  A Rhodes; J B Eastwood; S A Smith
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

8.  Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.

Authors:  Tanya C McCarthy; P Timothy Pollak; Elyisha A Hanniman; Christopher J Sinal
Journal:  J Pharmacol Exp Ther       Date:  2004-07-20       Impact factor: 4.030

Review 9.  Fatal amiodarone-induced hepatotoxicity: a case report and literature review.

Authors:  A L F Chan; H J Hsieh; Y-A Hsieh; S-J Lin
Journal:  Int J Clin Pharmacol Ther       Date:  2008-02       Impact factor: 1.366

10.  Probable early acute hepatitis with parenteral amiodarone.

Authors:  J Lupon-Rosés; R Simó-Canonge; L Lu-Cortez; G Permanyer-Miralda; H Allende-Monclús
Journal:  Clin Cardiol       Date:  1986-05       Impact factor: 2.882

View more
  1 in total

Review 1.  Gastrointestinal Side Effects of Antiarrhythmic Medications: A Review of Current Literature.

Authors:  Waseem Amjad; Waqas Qureshi; Ali Farooq; Umair Sohail; Salma Khatoon; Sarah Pervaiz; Pratyusha Narra; Syeda M Hasan; Farman Ali; Aman Ullah; Steven Guttmann
Journal:  Cureus       Date:  2017-09-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.